Scientists Unveil Safer Way To Treat Inflammatory Eye Diseases
A study found that injecting mesenchymal stem cells into periocular tissue effectively reduces eye inflammation without ...
Knowridge2 天
A safer way to treat inflammatory eye diseases
Dr. Shimmura explained that this therapy offers two major benefits: it reduces inflammation and promotes healing at the same ...
Stem cell shots: Unveiling a safer way to treat inflammatory eye diseases
Graft-versus-host disease (GVHD) is a common and severe complication that occurs after stem cell transplantation, where the ...
Healio3 天
Challenging cornea cases may require complex treatment course
OSN, a roundtable discusses the management of epithelial ingrowth after LASIK, neurotrophic keratitis and Demodex blepharitis with marginal keratitis.A few thoughts after decades of treating these ...
Aurion Biotech Pursues IPO For Cornea Disease Treatments
Aurion Biotech, Inc. plans $100M IPO for corneal disease treatments, limited competition, Phase 1/2 trials underway with ...
Medscape24 天
Ultraviolet A and Riboflavin Therapy as an Adjunct in Corneal Ulcer Refractory to Medical ...
On the left eye, the patient had conjunctival congestion and hyperemia, a central 2- × 2-mm corneal epithelial defect with deep stromal infiltration, endothelial plaque, moderate anterior chamber ...
Morningstar28 天
First FDA-Approved Mesenchymal Stromal Cell Therapy Ushers in a New Era of Regenerative ...
NEW YORK, Jan. 16, 2025 /PRNewswire/ -- The Food and Drug Administration (FDA) approved the first mesenchymal stromal cell (MSC) therapy, RYONCIL®, indicated for steroid-refractory acute graft ...
ophthalmologyadvisor29 天
Use Topical Losartan With Caution in Setting of Corneal Epithelial Defect
Group 3 rabbits stopped treatment and were euthanized at 9 days because they had experienced too much toxicity, which included peripheral corneal neovascularization, increasing stromal opacity in ...